Adeka reports strong profit growth in first half of FY2026

Adeka Corporation achieved consolidated net sales of JPY195,710 million for the six months ended September 30, 2025, a slight increase of 0.3% year-on-year. Operating profit surged by 8.0% to JPY19,765 million, and ordinary profit rose by 18.6% to JPY19,999 million. Profit attributable to owners of parent increased by 8.1% to JPY12,419 million. The Life Science business was a key driver, with net sales growing by 21.9% to JPY47,705 million and operating profit soaring by 560.2% to JPY4,160 million.

Conversely, the Chemicals business experienced a decline, with net sales down 6.1% to JPY104,881 million and operating profit decreasing by 13.2% to JPY13,043 million, primarily due to weakness in Polymer Additives and Semiconductor Materials segments. Despite these mixed results, Adeka maintained its full-year fiscal 2026 forecast, projecting net sales of JPY441,000 million and profit attributable to owners of parent of JPY26,400 million.

The company's financial position remains stable, with total assets at JPY542,359 million and net assets at JPY359,632 million as of September 30, 2025. Adeka also actively managed its capital, acquiring 1,406,300 treasury shares for JPY4,589 million during the period, contributing to a total of JPY9,090 million in treasury shares by the end of the six months.